Worldwide Hemoglobinopathies Market forecasts on regional growth, industry players and more

1
Hemoglobinopathies Market share research by
applications and regions for 2016 2023 Global
Market Insights Inc.
Fuel Cell Market size worth 25.5bn by 2024
2
Regional Analysis of Hemoglobinopathies Market

• In 2015, North America was the largest revenue
  generating region with around USD 1.2 billion
  owing to rise in RD investments, better
  compensation state, and presence of high quality
  healthcare infrastructure. Asia Pacific
  hemoglobinopathies market share is anticipated to
  increase at 9 CAGR due to rising patient
  awareness and introduction of manufactured and
  low cost diagnostic kits. Sickle cell anemia is
  the most prevalentdisease in West Africa, with
  nearly 20 of people having sickle cell trait and
  about 2 of total babies born with a form of the
  disease. In many regions of Europe, hemoglobin
  (Hb) disorders are classified as prevalent
  diseases.
• In the U.S., nearly 1,000 babies are born with
  sickle cell diseases every year. Increasing
  pervasiveness of several hemoglobinopathy
  disorders and high level of awareness about
  related genetic testing has boosted regional
  growth. The disease does not have a permanent
  treatment resulting in growing demand for novel
  products in the pharmaceutical industry.

3

• Application Analysis of Hemoglobinopathies Market
  
• Most common tools/tests for diagnosis of
  hemoglobinopathies and thalassemia disorders are
  pre-implantation genetic diagnosis, genetic and
  blood testing, alkaline and acid gel
  electrophoresis, hemoglobin electrophoresis,
  prenatal genetic testing and HbA2 quantification
  by ion exchange column chromatography. Increased
  awareness about genetic testing for diagnosis of
  sickle cell anemia and other disorders is
  expected to contribute toward revenue growth in
  the near future. Genetic testing is an emerging
  cost-effective approach to reduce the
  pervasiveness of the disease.

4
Competitive Market Share of Hemoglobinopathies
Market

• Key industry players comprise Alnylam
  Pharmaceuticals, Gamida Cell, Biogen Idec,
  AcceleronPharma, Sangamo BioSciences, Anthera
  Pharmaceuticals, Global Blood Therapeutics,
  Genetix Pharmaceuticals, Mast Therapeutics,
  Prolong Pharmaceuticals, Emmaus Medical, Calgene
  Corporation, Invenux, Optinova Ab, and HemaQuest
  Pharmaceuticals. Companies are aiming on the
  partnership and licensing deals for sharing the
  research and development platform. In 2014,
  Sangamo BioSciences and Biogen Idec declared
  collaboration agreement that targeted
  hemoglobinopathies market therapeutics
  development.

5

Browse Full Market Research Report On
Hemoglobinopathies Market _at_ https//goo.gl/ccaZoW
Request for an in-depth table of contents for
this report _at_ https//www.gminsights.com/request-t
oc/upcoming/470 Gaming Console Market
6
Stay In Touch Website www.gminsights.com Soci
al Media